Target Of Rapamycin (TOR) pathway has an evolutionary conserved role in the control of growth, metabolism, stress response, survival and ageing.

Currently « TOR de France » is a unique conference series in the world entirely devoted to field of « Target Of Rapamycin » signaling, nutrition, growth, metabolism, development. The « TOR de France » meeting gathers students, postdocs, research group leaders and medical doctors working on various aspects of TOR biology and the applications in medicine, pharmacology, human health. This pluridiplinary approach allows new and fruitful feedbacks on everyone’s work and have proven to foster innovative collaborations.

 

En savoir plus